Lyra Therapeutics (NASDAQ:LYRA) Lowered to Neutral at HC Wainwright
HC Wainwright lowered shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm currently has $2.00 target price on the stock, down from their previous target price of $12.00. A number of other research analysts […]
More Stories
Phunware (NASDAQ:PHUN) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst Says
Phunware (NASDAQ:PHUN – Get Free Report) had its price objective hoisted by research analysts at Ascendiant Capital Markets from $12.00...
Rubrik (NYSE:RBRK) Price Target Raised to $115.00
Rubrik (NYSE:RBRK – Get Free Report) had its target price lifted by equities researchers at Cantor Fitzgerald from $95.00 to...
IperionX (NASDAQ:IPX) Upgraded at Wall Street Zen
IperionX (NASDAQ:IPX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to...
D. Boral Capital Reaffirms Buy Rating for Nano-X Imaging (NASDAQ:NNOX)
Nano-X Imaging (NASDAQ:NNOX – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research...
Barclays Begins Coverage on Sweetgreen (NYSE:SG)
Equities researchers at Barclays started coverage on shares of Sweetgreen (NYSE:SG – Get Free Report) in a note issued to...
Needham & Company LLC Has Lowered Expectations for Lululemon Athletica (NASDAQ:LULU) Stock Price
Lululemon Athletica (NASDAQ:LULU – Get Free Report) had its price target lowered by stock analysts at Needham & Company LLC...